EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases

Shih-Wen Huang, Yein-Gei Lai iD, Hao-Ting Liao iD, Chin-Ling Chang, Ruo-Yu Ma, Yung-Hsiang Chen, Yae-Huei Liou, Zhen-Qi Wu, Yu-Chen Wu, Ko-Jiunn Liu, Yen-Tsung Huang, Jen-Lung Yang und 2 weitere

eLife · 2025

DOI: 10.7554/elife.99010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Shih-Wen Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan. Hauptthemen laut MEDLINE: Killer Cells, Natural, Lung Neoplasms, Dendritic Cells, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, Academia Sinica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells can control metastasis through cytotoxicity and IFN-γ production independently of T cells in experimental metastasis mouse models. The inverse correlation between NK activity and metastasis incidence supports a critical role for NK cells in human metastatic surveillance. However, autologous NK cell therapy has shown limited benefit in treating patients with metastatic solid tumors. Using a spontaneous metastasis mouse model of MHC-I + breast cancer, we found that transfer of IL-15/IL-12-conditioned syngeneic NK cells after primary tumor resection promoted long-term survival of mice with low metastatic burden and induced a tumor-specific protective T cell response that is essential for the therapeutic effect. Furthermore, NK cell transfer augments activation of conventional dendritic cells (cDCs), Foxp3 - CD4 + T cells and stem cell-like CD8 + T cells in metastatic lungs, to which IFN-γ of the transferred NK cells contributes significantly. These results imply direct interactions between transferred NK cells and endogenous cDCs to enhance T cell activation. We conducted an investigator-initiated clinical trial of autologous NK cell therapy in six patients with advanced cancer and observed that the NK cell therapy was safe and showed signs of effectiveness. These findings indicate that autologous NK cell therapy is effective in treating established low burden metastases of MHC-I + tumor cells by activating the cDC-T cell axis at metastatic sites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalLung NeoplasmsDendritic CellsBreast NeoplasmsT-LymphocytesAnimalsMiceHumansFemaleNeoplasm MetastasisDisease Models, AnimalLymphocyte ActivationMice, Inbred C57BLInterferon-gamma

Stichwörter der Autor:innen

T celldendritic cellhumanimmunologyinflammationmetastatic cancermousenatural killer cell

Substanzen

Interferon-gamma

Autor:innen und Institutionen

  • Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
  • Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan.
  • Department of Life Sciences, National Central University, Taoyuan, Taiwan.
  • National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
  • Institute of Statistical Science, Academia Sinica, Taipei, Taiwan.
  • Department of Hematology-Oncology, Tri-Service General Hospital, Taipei, Taiwan.

ORCID-Profile: Yein-Gei Lai, Hao-Ting Liao, Nan-Shih Liao

Förderung

  • Ministry of Science and Technology, Taiwan
  • Academia Sinica

Zitieren

APA

Huang, S. W., Lai, Y. G., Liao, H. T., Chang, C. L., Ma, R. Y., Chen, Y. H., Liou, Y. H., Wu, Z. Q., Wu, Y. C., Liu, K. J., Huang, Y. T., Yang, J. L., Dai, M. S., & Liao, N. S. (2025). Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases. eLife. https://doi.org/10.7554/elife.99010

Vancouver

Huang SW, Lai YG, Liao HT, Chang CL, Ma RY, Chen YH, et al. Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases. eLife. 2025. doi:10.7554/elife.99010

BibTeX
@article{Huang2025,
  author = {Huang, Shih-Wen and Lai, Yein-Gei and Liao, Hao-Ting and Chang, Chin-Ling and Ma, Ruo-Yu and Chen, Yung-Hsiang and Liou, Yae-Huei and Wu, Zhen-Qi and Wu, Yu-Chen and Liu, Ko-Jiunn and Huang, Yen-Tsung and Yang, Jen-Lung and Dai, Ming-Shen and Liao, Nan-Shih},
  title = {Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.99010}
}
Kostenlos starten →